Stock listing
NAMS Stock Price, News, Filings & Events — Newamsterdam Pharma Company N.v.
Selected listing: NAMS · NASDAQ · USD · US
This page tracks Newamsterdam Pharma Company N.v.'s NAMS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NAMS:NASDAQ. NAMS:NASDAQ is the stock-level entry point for investors researching Newamsterdam Pharma Company N.v., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Newamsterdam Pharma Company N.V. is a publicly traded company listed under the ticker NAMS in the American market. With a market capitalization of approximately $3.7 billion, the company focuses on developing innovative pharmaceutical solutions. Their commitment to advancing healthcare is reflected in their ongoing research and development efforts.
- Ticker
- NAMS:NASDAQ
- Asset type
- Stock
- Market cap
- $3.34B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Newamsterdam Pharma Company N.v. NAMS:NASDAQ stock context
This page tracks Newamsterdam Pharma Company N.v.'s NAMS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NAMS:NASDAQ. NAMS:NASDAQ is the stock-level entry point for investors researching Newamsterdam Pharma Company N.v., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Newamsterdam Pharma Company N.V. is a publicly traded company listed under the ticker NAMS in the American market. With a market capitalization of approximately $3.7 billion, the company focuses on developing innovative pharmaceutical solutions. Their commitment to advancing healthcare is reflected in their ongoing research and development efforts.
Latest news from Newamsterdam Pharma Company N.v.
NewAmsterdam Pharma Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026
August 26, 2026
NewAmsterdam Pharma to Host Investor Day on August 5, 2026
July 29, 2026
NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monoth...
July 24, 2026
NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions
June 3, 2026
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in May
May 11, 2026
Newamsterdam Pharma Company N.v. earnings calls
Research Newamsterdam Pharma Company N.v.
Newamsterdam Pharma Company N.v. investor report
Review AI stock analysis and investor report context for NAMS:NASDAQ.
Newamsterdam Pharma Company N.v. company profile
View the public company page for Newamsterdam Pharma Company N.v. on 6ix.
Newamsterdam Pharma Company N.v. news
Read company news and market updates connected to Newamsterdam Pharma Company N.v..
Newamsterdam Pharma Company N.v. investor events
Find investor webinars, events, and replay context for Newamsterdam Pharma Company N.v..
Alternate listings
KH6:GETTEX
DE · EUR
Alternate listing for Newamsterdam Pharma Company N.v.; the primary context on this page is NAMS:NASDAQ.
A3DUAC:LSX
DE · EUR
Alternate listing for Newamsterdam Pharma Company N.v.; the primary context on this page is NAMS:NASDAQ.
KH6:TRADEGATE
DE · EUR
Alternate listing for Newamsterdam Pharma Company N.v.; the primary context on this page is NAMS:NASDAQ.
NAMS:BOATS
US · USD
Alternate listing for Newamsterdam Pharma Company N.v.; the primary context on this page is NAMS:NASDAQ.
A3DUAC:LS
DE · EUR
Alternate listing for Newamsterdam Pharma Company N.v.; the primary context on this page is NAMS:NASDAQ.
KH6:DUS
DE · EUR
Alternate listing for Newamsterdam Pharma Company N.v.; the primary context on this page is NAMS:NASDAQ.
KH6:FWB
DE · EUR
Alternate listing for Newamsterdam Pharma Company N.v.; the primary context on this page is NAMS:NASDAQ.
KH6:HAM
DE · EUR
Alternate listing for Newamsterdam Pharma Company N.v.; the primary context on this page is NAMS:NASDAQ.
KH6:MUN
DE · EUR
Alternate listing for Newamsterdam Pharma Company N.v.; the primary context on this page is NAMS:NASDAQ.
KH6:SWB
DE · EUR
Alternate listing for Newamsterdam Pharma Company N.v.; the primary context on this page is NAMS:NASDAQ.